Revvity | PKI - 销售和管理费用



金融业
股票价格
USD 154.39
资产
USD 11.49B
现金及等价物
USD 592.8M
销售成本
USD 310.32M
流动资产
USD 1.86B
流动负债
USD 701.48M
债务
USD 2.63B
股息收益率
0.19
EBIT
USD 124.63M
EBITDA
USD 227.55M
员工
11K
EPS每股收益
USD 1.37
股本和储备
USD 7.23B
销售毛利
USD 418.58M
债务利息支出
USD 20.81M
利息收入
USD -22.99M
贷款资金
USD 2.63B
市值
USD 18.91B
净收入
USD 62.3M
营业费用
USD 604.27M
营业利润
USD 124.63M
普通股股本
USD 111.59M
PE价格收益
56.86
税前利润
USD 187.24M
销售收入
USD 729M
销售和管理费用
USD 275.33M
股票
USD 388.85M
贸易债权人
USD 163.27M
应收帐款人
USD 687.33M


销售和管理费用 更改 日
Agilent USD 475M 10M 2026-06
Align Technology USD 410.55M 52.12M 2026-09
Bio Techne USD 67.42M 41.91M 2026-06
Bio-Rad Laboratories USD 212M 400K 2026-06
Bruker USD 226.5M 12.4M 2026-09
Celltrion KRW 12.72B 3.4B 2026-06
Charles River Laboratories USD 140.59M 88.31M 2026-09
Cspc Pharmaceutical CNY 1.87B 95.62M 2025-12
Danaher USD 2.16B 87M 2026-09
Dentsply International USD 363M 1000K 2026-09
Deva Holding AS TRY 462.26M 48.18M 2023-09
Dianthus Therapeutics USD 13.56M 1.09M 2026-06
Divis Laboratories Ltd INR 3.4B 10M 2025-06
Edwards Lifesciences USD 560.9M 300K 2026-09
Illumina USD 281M 8M 2026-09
Intuitive Surgical USD 1.08B 465.5M 2026-09
IQVIA Holdings USD 569M 5M 2026-09
Kangmei Pharma CNY 253.72M 16.66M 2026-06
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Laboratorios Farma EUR 35.32M 2.75M 2025-06
Laboratory Of America USD 611.4M 34.2M 2026-09
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 2.84M 4.19M 2025-12
Mesa Laboratories USD 27.31M 380K 2024-09
Mettler Toledo International USD 267.16M 3.82M 2026-09
Myriad Genetics USD 122.3M 6.7M 2025-12
Neuren Pharmaceuticals AUD 3.74M 2.5M 2025-12
OraSure Technologies USD 13.21M 3.29M 2025-12
Organigram Holdings CAD 26.51M 4.5M 2026-06
Ovoca Bio EUR 617K 15K 2025-12
Pacific Biosciences Of California USD 37.24M 25.68M 2025-12
Pharma Mar EUR 15.53M 1.59M 2026-09
Qiagen NV USD 142.33M 60K 2026-06
Quest Diagnostics USD 523M 6M 2026-09
Quidel USD 182.7M 7M 2026-09
Repligen USD 83.59M 6.97M 2026-09
Revvity USD 275.33M 3.25M 2026-09
Sartorius EUR 216.6M 4.7M 2026-09
Sino Biopharmaceutical CNY 7.54B 2.23B 2025-06
Thermo Fisher Scientific USD 1.86B 46M 2026-09
Tilray USD 24.85M 1.7M 2025-09
Waters USD 398M 7M 2026-09
Zealand Pharma A/S 104M 12.19M 2026-03
Zz Pientze Pharmaceu CNY 267.85M 44.71M 2026-09